| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
SRX Health Solutions, Inc.$1.48
+0.03 (+2.07%)
Market Cap
74.96 M
EPS
-
P/E Ratio
-
Value Trade
3.71 M
SEC Financials
Q1 2026Dilution Risk
Revenue
3.44 M
Total Assets
43.36 M
Total Liabilities
25.08 M
Equity
18.29 M
D/E Ratio
12,345
-9.29 %
Week
5.83 %
1 Month
1.36 %
3 Month
-48.81 %
6 Month
-100 %
5 Year
-100 %
All Time
Cash Data
Cash Position
23.54 M
Monthly Burn
606.00 K
Runway
36.3 mo
Burn Trend
SEC Filing
May 14, 2026
Overview
Volume
1.75 M
52 Week Range
0.08 - 0.78
% held by Insiders
1.92 %
% held by Institutions
0.13 %
Enterprise Value
71.51 M
Total Shares
591.20 M
Short %
14.06 %
Float Shares
147.21 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SRXH
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SRXH Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SRXH▲ +2.1%today
SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering
SRX Global Inc. has announced its acquisition of shares in the initial public offering of Jersey Mike's, which is valued at $1 billion. The IPO priced its Class A common shares at $23.00 each and began trading on the NYSE under the ticker JMKE. SRX Global aims to generate long-term shareholder value through strategic investments.
Read more →SRXH▲ +40.6%on this news
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
SRX Global Inc. has authorized a share repurchase program allowing for the buyback of up to 10 million shares, representing 50% of its outstanding shares. The company plans to allocate $20 million for this initiative, which reflects its strong cash position and confidence in its long-term strategy. The repurchase may occur through various methods, depending on market conditions.
Read more →SRXH▼ -66.6%on this newsshared move
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
SRX Global, Inc. has announced a strategic investment in Greenland Mines Ltd., a company focused on critical and precious minerals development in Greenland. This investment aims to enhance SRX's portfolio and support the development of a multi-asset platform that includes rare earth materials and precious metals. Greenland Mines is working towards linking Greenland's resources with industrial infrastructure in allied jurisdictions.
Read more →SRXH▼ -66.6%on this newsshared move
SRX Global Announces Share Consolidation
SRX Global, Inc. announced a 60-to-1 share consolidation effective July 6, 2026. This move is expected to streamline the company's stock structure and enhance shareholder value. The common stock will continue to trade under the symbol 'SRXH' and will adopt a new CUSIP number. Shareholders will receive whole shares in lieu of any fractional shares.
Read more →SRXH▼ -18.7%on this news· ran to -73% by day 1shared move
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
SRX Global has made a strategic investment in ARMR Sciences, a clinical-stage company focused on developing medical countermeasures against synthetic drugs like fentanyl. ARMR's lead product, ARMR-100, has shown success in generating an anti-fentanyl immune response in humans. The next phase of trials is set to evaluate its effectiveness against fentanyl, aiming for a long-lasting preventive solution.
Read more →SRXH▼ -37.6%on this news· ran to -85% by day 3shared move
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
SRx Health Solutions has completed the acquisition of EMJ Crypto Technologies, rebranding as SRX Global. The company will focus on an AI-driven strategy for capital allocation into high-potential assets. CEO Kent Cunningham emphasized the synergies between the two firms, aiming to enhance shareholder returns. The stock will continue trading under the ticker SRXH.
Read more →SRXHSRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)
SRx Health Solutions has acquired a 4.99% stake in Smartkem, Inc. as part of a strategic investment. This acquisition was made through a shelf take down and includes the purchase of convertible preferred securities. The company has filed a Registration Statement with the SEC related to this transaction, which will provide further details to shareholders.
Read more →SRXHSRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update
SRx Health Solutions has updated its portfolio, initiating an investment in Uber Technologies, Inc. The company has also reduced its long position in Compass and trimmed its short exposure to Bitcoin, reflecting a cautious approach due to a shift in their EMJX stress model to STRESS. This marks the first negative market reading since the bull rotation began in April 2026.
Read more →SRXH▲ +9.8%on this news
SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)
SRx Health Solutions and EMJX have invested in Optimi Health Corp., a commercial-stage pharmaceutical company focused on psychedelic drug products. This investment is driven by strong insider ownership and favorable industry trends, particularly after a recent executive order aimed at accelerating psychedelic drug development. The companies are preparing for a proposed transaction, with relevant documents filed with the SEC.
Read more →SRXH▼ -9.4%on this news
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
SRx Health Solutions has received board approval to distribute 75% of profits from its investment in Astro Investment XVII, which is affiliated with Astro Capital. This investment, exceeding 10% of the company's capital, aims to capitalize on growth in artificial intelligence and space industries. The company plans to return capital to shareholders following the SPV's wind down.
Read more →SRXH▼ -8.2%on this news· ran to -24% by day 3shared move
SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026
SRx Health Solutions reported a 23% revenue growth for Q2 FY26, reaching $3.4 million. The company improved its liquidity position with $20.5 million in cash, while its active cryptocurrency strategy limited losses compared to market declines. Despite these positive developments, the company still faces challenges, including a significant adjusted EBITDA loss and net loss. A planned acquisition of EMJX is anticipated to bolster its capabilities in digital assets.
Read more →SRXH▲ +25.8%on this newsshared move
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
SRx Health Solutions has invested over 10% of its capital in Astro Investment XVII, an affiliate of Astro Capital, which focuses on AI and space investments. This move aligns with the company's strategy to leverage high-growth sectors through technology partnerships. The investment is part of a broader merger agreement with EMJ Crypto Technologies, aiming to enhance shareholder value.
Read more →SRXHSRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital Company has invested greater than 10 % of its investable capital in the convergence of Artificial Intelligence ("AI") and space through
SRx Health Solutions, Inc. has made a strategic investment of over 10% of its investable capital in Astro Investment XVII, affiliated with Astro Capital, focusing on the convergence of artificial intelligence and space. The investment is anticipated to facilitate growth opportunities for the company and its shareholders, demonstrating confidence in these burgeoning sectors. Additionally, the company has entered a definitive merger agreement with EMJ Crypto Technologies, which could further enhance its market position.
Read more →SRXHSRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
SRx Health Solutions and EMJ Crypto Technologies have updated shareholders on their merger agreement. Eric M. Jackson, founder of EMJX, highlighted the operational progress made since the announcement, including significant returns on investments. The company is committed to maximizing shareholder value and has filed a registration statement with the SEC to proceed with the merger.
Read more →SRXHSRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge
SRx Health Solutions has announced a strategic move to hedge its decentralized finance portfolio by investing in gold while reducing its hedge on emerging markets. The company is optimistic about the upcoming merger with EMJ Crypto Technologies, which is expected to close soon. This decision reflects a proactive approach to managing risks associated with market volatility.
Read more →SRXHSRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
SRx Health Solutions has launched EventHorizonIQ, a subscription service providing institutional-grade cross-asset regime intelligence. This platform offers real-time market state classifications based on various quantitative sensors, including macroeconomic and crypto data. The service aims to equip investors with timely diagnostic intelligence for better risk assessments and capital allocation decisions.
Read more →SRXHSRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings
SRx Health Solutions has announced a 30% increase in its ownership stake in Opendoor Technologies, a digital platform for real estate transactions. Additionally, the company has reduced its short position in cryptocurrencies, now holding a net long position in Bitcoin and Ethereum. This move reflects a strategic shift towards optimism in both real estate and cryptocurrency markets.
Read more →SRXHSRx Health Solutions Announces Receipt of Warning Letter from NYSE American
SRx Health Solutions, Inc. received a warning letter from NYSE American for failing to comply with listing regulations. The company did not file for approval of additional share issuance and lacked proper stockholder consent for a conversion that exceeded 20% of outstanding shares. All preferred shares have since been converted or redeemed.
Read more →SRXHTony Frouge Chief Regulatory Officer New York Stock Exchange 11 Wall Street New York, NY 10005 T + 1 212 656 2133 tony.frouge@nyse.com
SRX Health Solutions, Inc. received a public Warning Letter from the NYSE for failing to comply with the Company Guide, specifically regarding the issuance of additional securities. The company issued approximately 7.5 million common shares without filing the required application for listing approval or obtaining shareholder consent. These actions constitute violations of Sections 301 and 713 of the NYSE Company Guide. The NYSE indicated that continued non-compliance may lead to delisting proceedings against the company.
Read more →SRXH▼ -16.2%on this news
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders
SRx Health Solutions has redeemed 17,500 shares of its Series A Preferred Stock, equivalent to approximately 125 million shares of common stock. This move is aimed at improving the company's balance sheet flexibility for potential future investments or returning capital to shareholders. Although there are no immediate M&A plans, the company will continue to evaluate opportunities.
Read more →SRXH▼ -16.2%on this newsshared move
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to
SRx Health Solutions, Inc. has redeemed 17,500 shares of its Series A Preferred Stock, which corresponds to the cancellation of approximately 125,000,000 shares of common stock. This action is intended to enhance the flexibility of the company's balance sheet for future investments or the return of capital to shareholders. Although there are no immediate plans for mergers and acquisitions (M&A), the company will continue to evaluate opportunities as they arise. The firm expects to file its Form 10-Q with the SEC soon.
Read more →SRXHSRx Health Solutions Launches EventHorizonIQ, a Public Ledger of AI-Generated Financial Market Instability Signals
SRx Health Solutions has launched EventHorizonIQ, a public ledger that records AI-generated signals of financial market instability. This platform, developed in collaboration with EMJ Crypto Technologies, aims to enhance financial infrastructure by providing a read-only record of market conditions. The signals are generated by AI agents and are designed to be rare and significant, reflecting underlying market states.
Read more →SRXH▲ +5.3%on this newsshared move
SRx Health Solutions Significantly Reduces Short Position of Cryptocurrency Portfolio Amidst Current Market Volatility
SRx Health Solutions has announced a significant reduction of its short position in its cryptocurrency portfolio, which includes Bitcoin and Ethereum. This decision is part of the company's strategy to manage capital allocation effectively amidst market volatility. The company aims to preserve long-term optionality and enhance shareholder returns without affecting its core operations.
Read more →SRXHSRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million
SRx Health Solutions has announced an additional capital allocation to its digital asset treasury management strategy, increasing its total investment to $18 million in Bitcoin and Ethereum. This move is part of a broader strategy to deploy excess liquidity into undervalued assets. The company remains focused on its core operations while adapting its investment strategy based on market conditions.
Read more →SRXH▼ -6.6%on this news· ran to -19% by day 3
SRx Health Solutions Invests in Common Stock of Opendoor Technologies
SRx Health Solutions has announced an investment in Opendoor Technologies as part of its capital allocation strategy. This move aims to leverage excess liquidity into undervalued securities and digital assets. SRXH sees potential in Opendoor's technology-enabled platform for real estate transactions, aligning with its investment objectives. The company may adjust its stake based on market conditions.
Read more →SRXH▼ -6.1%on this newsshared move
EMJX CEO Eric Jackson to Host Fireside Chat on EMJX Treasury OS Strategy and Governance on January 22nd
SRx Health Solutions, Inc. announced that Eric Jackson, CEO of EMJ Crypto Technologies, will host a virtual fireside chat on January 22, 2026. The discussion will cover EMJX's treasury operating system and its governance principles. Attendees will have the opportunity to engage in a live Q&A session following the presentation.
Read more →SRXHSRx Health Solutions Regains Compliance with
SRx Health Solutions, Inc. has successfully regained compliance with the NYSE American's listing standards, having its plan accepted after previously falling below the required stockholders' equity threshold. The company will have until July 14, 2026, to complete its proposed goals under the plan, during which it will provide quarterly updates to maintain transparency with the NYSE. This announcement follows a notification from the NYSE on October 14, 2025, regarding its prior non-compliance status.
Read more →SRXHSRx Health Solutions Deploys Initial $10 Million into Several Digital Assets Predominantly Bitcoin and Ethereum
SRx Health Solutions has announced an initial investment of $10 million into digital assets, primarily Bitcoin and Ethereum. This investment is part of a model-driven strategy aimed at preserving long-term optionality in volatile markets. The company emphasizes a measured approach rather than reacting to short-term market fluctuations. Updates on treasury operations are expected periodically.
Read more →SRXH▲ +23.8%on this news
SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson Upon closing, Eric M. Jackson to Lead Combined Company
SRx Health Solutions, Inc. has announced a definitive agreement to acquire EMJ Crypto Technologies (EMJX) to build a next-generation digital asset treasury platform. The move is aimed at transforming digital asset management with a focus on systematic risk controls and multi-asset flexibility, rather than relying on single asset holdings. Eric M. Jackson, the founder of EMJX, will assume dual roles as the Chief Executive Officer and Chairman once the acquisition is finalized in early 2026, pending shareholder approval. This strategic acquisition is part of SRx's vision for enhancing digital asset treasuries and fostering long-term growth through disciplined capital allocation.
Read more →SRXH▼ -7.5%on this news
SRx Health Solutions Appoints Sammy Dorf to Board of Directors TAMPA, FL
SRx Health Solutions, Inc. has announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Dorf brings extensive experience in the cannabis economy, having previously served as Executive Chairman of Flora Growth Corp. His track record includes guiding companies through innovative growth phases and emphasizing regulatory excellence. This move is seen as a strategic enhancement to SRx Health Solutions' leadership and potential future growth.
Read more →SRXHSRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency TAMPA, FL
SRx Health Solutions, Inc. received a notification from NYSE American regarding a deficiency in stockholders' equity, indicating non-compliance with continued listing standards. The company must submit a compliance plan by November 13, 2025, to address this issue. Despite this notification, there is no immediate effect on the trading of SRXH stock or its operational reporting requirements. The company has until July 14, 2026, to achieve compliance.
Read more →SRXHSRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
SRx Health Solutions, Inc. has appointed Joshua Epstein to its Board of Directors and Compensation Committee. This decision marks a strategic move aimed at enhancing the company's governance and oversight functions. Epstein's experience is expected to contribute positively to SRx's future direction and decision-making processes.
Read more →SRXH▼ -9.4%on this news· ran to +67% by day 1
SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock The Company intends to explore all available legal remedies against former officers of SRx Canada TAMPA, FL
SRx Health Solutions, Inc. has announced the cancellation of approximately 18.8 million shares of its capital stock as part of a settlement agreement with certain former officers of its Canadian subsidiary, SRx Canada. This decision follows an initial order under the Companies' Creditors Arrangement Act from the Ontario Superior Court of Justice. The company intends to pursue legal remedies against former officers who are not included in the settlement, aiming to recover lost value for its stockholders. The canceled shares represent about 60% of the previously outstanding shares.
Read more →SRXH▼ -12.5%on this news· ran to +32% by day 3shared move
SRx Health Solutions Initiates Restructuring Proceedings under CCAA for its Canadian Subsidiary U.S. operations, including Halo subsidiary, will not be affected by CCAA Proceedings; No U.S. bankruptcy filing expected TAM
SRx Health Solutions, Inc. has initiated restructuring proceedings under the Companies' Creditors Arrangement Act (CCAA) for its Canadian subsidiary, SRx Health Solutions (Canada). This move aims to protect creditors and provide the company with time to restructure its financial situation while maintaining critical business functions. Importantly, the U.S. operations and the Halo subsidiary will not be impacted by these proceedings. The company intends to seek debtor-in-possession financing to support its restructuring efforts.
Read more →SRXH▲ +6.9%on this news
SRx Health Solutions Announces Management and Board Changes TAMPA, FL
SRx Health Solutions, Inc. has made significant management changes by appointing Kent Cunningham as CEO and transitioning Adesh Vora to the role of Executive Chairman. This leadership adjustment is effective immediately and reflects the company's strategy to enhance governance and operational focus. SRx Health Solutions operates comprehensively across Canada, aiming to improve patient care and wellness through its integrated healthcare services. These changes may influence the company's approach to future initiatives and its overall performance in the specialty healthcare market.
Read more →SRXHSRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million TAMPA, FL
SRx Health Solutions, Inc. has successfully completed a $7.3 million financing round, primarily supported by insiders and existing investors. In addition, the company has secured a $50 million equity line of credit, significantly strengthening its financial position and allowing for the pursuit of growth opportunities. The funds will be directed toward acquiring new assets in the U.S. and expanding its specialty pharmaceutical operations in Canada. This strategic financial positioning aims to enhance operational efficiency and patient access.
Read more →SRXHBetter Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price TAMPA, FL
Better Choice Company has successfully closed its merger with SRx Health Solutions and secured $8.8 million in a private placement. As part of this merger, the company will change its name to SRx Health Solutions Inc. and update its ticker symbol to SRXH, effective April 30, 2025. This move aims to position the company as a leader in the pet health and wellness market by providing better products for pets and their owners. The company plans to leverage this merger to further grow its portfolio and enhance its market presence.
Read more →SRXHSRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of
SRx Health Solutions, Inc., formerly Better Choice Company Inc., has announced a new stock distribution to its shareholders. Effective April 25, 2025, stockholders of record will receive one share of Halo Spin-Out SPV Inc. for each share they hold. The distribution is part of a recent business combination transaction, and the company will adopt its new ticker symbol 'SRXH' on the NYSE American starting April 30, 2025. This rebranding and spin-out aim to enhance the company's position within the integrated specialty healthcare market.
Read more →SRXHSource: Better Choice Company Inc.
Better Choice Company Inc. announced the sale of its Asian business, conducted by its subsidiary Halo, Purely for Pets, Inc., to CZC Company LTD for $8.1 million. The deal includes $6.5 million in cash and a five-year royalty agreement that guarantees a minimum total payment of $1.65 million. This sale is part of the company’s strategy to concentrate on its health and wellness products and maximize shareholder value. The company retains ownership of its North American and global operations outside Asia, allowing a focused approach on core markets.
Read more →SRXHBetter Choice Company Adjourns Special Meeting of Stockholders to
Better Choice Company has adjourned its special meeting of stockholders to March 21, 2025, to facilitate further shareholder participation regarding proposals in its proxy statement, including an arrangement transaction with SRx Health Solutions. The adjournment follows a quorum where approximately 71% of shares were represented, with sufficient votes supporting the proposals. The company aims to provide updated materials to allow stockholders to make informed decisions ahead of the rescheduled meeting.
Read more →SRXHBetter Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition Combined company will emerge as a leading global health and wellness co
Better Choice Company is progressing towards closing its acquisition of SRx Health Solutions, valued at approximately $125 million. The merger aims to position the combined entity as a leading global health and wellness company, with projected revenue exceeding $270 million by 2025. The acquisition is anticipated to generate significant cash flow and operational efficiencies while providing new growth opportunities in various markets. As the companies integrate, Better Choice plans to expand into the veterinary sector and new geographic regions.
Read more →SRXHBETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2024 RESULTS Net Income Increased 190% to $2.7 million Year-Over-Year EPS Growth of 170% to $2.98 Year-Over-Year Adjusted EBITDA Increased 98% to less than $(0.1) milli
Better Choice Company Inc. reported strong financial results for the second quarter of 2024, with a notable increase in net income and EPS. The company achieved a net income of $2.7 million, marking a 190% increase year-over-year, while EPS improved by 170% to $2.98. The strategic efforts to revamp operations and enhance financial governance are showing positive outcomes, as evidenced by the significant improvement in Adjusted EBITDA and operating losses. The company's growth strategies in both domestic and international markets remain a focal point for future expansion.
Read more →SRXHBetter Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Better Choice Company Inc. received notification from the NYSE American regarding noncompliance with its continued listing standards due to insufficient stockholders' equity and reported fiscal losses. The company has a deadline of May 24, 2024, to submit a compliance plan to address these issues, which it is in the process of preparing. Despite the noncompliance notice, the company's common stock will continue to be listed and traded, though it will bear a designation indicating its status. However, failure to meet the requirements by October 24, 2025, could result in delisting from the exchange.
Read more →SRXHBetter Choice Company Board of Directors Authorize Stock Repurchase Program
Better Choice Company Inc. announced the authorization of a stock repurchase program allowing for the buyback of up to $5 million of its common stock by December 31, 2024. The repurchases may occur in open market or private transactions, at the discretion of market conditions and financial performance. This decision highlights the company's strategic focus on enhancing shareholder value while navigating the evolving pet health and wellness market.
Read more →SRXHBETTER CHOICE COMPANY, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 32% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, FLOR
Better Choice Company, Inc. announced its financial results for the fourth quarter and full year 2023, highlighting a significant improvement in gross margin, which increased by 300 basis points to 31% year-over-year. The company also reported a 32% increase in adjusted EBITDA and a 45% growth in earnings per share. However, while overall financial performance showed improvement, a decline in net sales was noted due to strategic decisions such as exiting unprofitable accounts and adapting to market conditions. Looking ahead, Better Choice is implementing strategic shifts to enhance brand growth and profitability.
Read more →SRXHBETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 million Adjusted EBITDA Growth of 95% Year-Over-Year EPS Growth of 77% Year-Over-Year TAMPA, FL
Better Choice Company, Inc. reported its third-quarter financial results for 2023, showcasing significant revenue growth of 11% year-over-year, amounting to $13.1 million. Adjusted EBITDA saw a remarkable increase of 95% year-over-year, which underscores the company's operational improvements. The net loss also showed a substantial decrease of 75% compared to the same quarter last year. Despite these positive trends, the company continues to operate at a loss with a negative operating margin.
Read more →SRXHDocument BETTER CHOICE COMPANY INC. ANNOUNCES SECOND QUARTER 2023 RESULTS Enhanced Operational and Financial Discipline 33% Growth in EPS Year-Over-Year Gross Margin Growth of 543 Basis Points Year-Over-Year Increased Op
Better Choice Company Inc. has announced its second-quarter results for 2023, highlighting a 33% increase in earnings per share and significant improvements in gross margin. Despite facing challenges related to supply chain constraints, the company's operational and financial performance showed notable progress with a 14% increase in net revenues from the prior quarter. The newly appointed CEO emphasized the importance of enhancing operational discipline and leveraging a strategic partnership with Alphia to mitigate supply risks. Although there were product availability challenges, the company remains optimistic about future growth and profitability.
Read more →SRXHDocument Better Choice Company Reports First Quarter 2023 Financial Results Gross Margin Improved to 35% Year-over-Year
Better Choice Company reported its financial results for Q1 2023, revealing a gross margin improvement to 35% year-over-year. The company generated $9.2 million in net sales, bolstered by strong performance from its Halo Holistic product line, which saw a significant increase in international e-commerce sales. However, there was a notable decline in net revenue compared to the previous quarter, alongside ongoing operational losses. The company remains optimistic about future growth due to restructuring plans and improvements in operating efficiencies.
Read more →SRXHDocument Better Choice Announces Streamlining of Operations and Reduction in Workforce
Better Choice Company Inc. has announced a significant reduction in its workforce, impacting around 25% of its employees, as part of a broader effort to streamline operations. The company expects to achieve annual savings of approximately $2.2 million and has eliminated the role of COO to lower its cost structure. Despite the immediate challenges, the interim CEO, Lionel Conacher, believes there are strong long-term opportunities ahead, although he acknowledged market weaknesses. Additional details will be shared during the upcoming financial results report for Q4 and the full year 2022.
Read more →SRXHDocument Better Choice Company Reports Third Quarter 2022 Financial Results and Provides Operational and Corporate Updates Year-to-Date Net Sales Totaled $45.4 million, an Increase of 30% Year-over-Year Gross Profit and
Better Choice Company Reports Third Quarter 2022 Financial Results and Provides Operational and Corporate Updates Year-to-Date Net Sales Totaled $45.4 million, an Increase of 30% Year-over-Year Gross Profit and Adjusted Gross Profit Margins Improved to 35% and 37% for the Third
Read more →SRXHDocument Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update Better Choice Reports Record Second Quarter 2022 Gross Sales of $19.8 Million and Net Sales of $16.5 Million, Re
Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update Better Choice Reports Record Second Quarter 2022 Gross Sales of $19.8 Million and Net Sales of $16.5 Million, Representing a Quarter-Over-Quarter Increase in Net Sales of 50%, Driv
Read more →SRXHDocument Better Choice Company Reports Record First Quarter 2022 Gross Sales of $19.7 Million and Net Sales of $17.0 million, an Increase of 57% Year-Over-Year
Better Choice Company Reports Record First Quarter 2022 Gross Sales of $19.7 Million and Net Sales of $17.0 million, an Increase of 57% Year-Over-Year NEW YORK, NY, May 12, 2022 -- Better Choice Company Inc. (NYSE BTTR) (the "Company" or "Better Choice"), a pet health and welln
Read more →SRXHDocument Better Choice Company Board of Directors Authorize Stock Repurchase Program
Better Choice Company Board of Directors Authorize Stock Repurchase Program NEW YORK, NY, May 12, 2022 -- Better Choice Company Inc. (NYSE BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, announces that its Board of Directors has authorized a stock re
Read more →SRXHDocument Better Choice Company Reports Fourth Quarter and Full Year 2021 Financial Results, Provides Update to Halo Elevate Launch and Releases First Quarter 2022 Growth Estimate
Better Choice Company Reports Fourth Quarter and Full Year 2021 Financial Results, Provides Update to Halo Elevate Launch and Releases First Quarter 2022 Growth Estimate NEW YORK, NY, March 29, 2022 -- Better Choice Company Inc. (NYSE American BTTR) (the "Company" or "Better Cho
Read more →SRXHDocument Better Choice Company Reports Record Third Quarter 2021 Financial Results and Provides Update to Target Store Count for 2022 Launch of Halo Elevate
Better Choice Company Reports Record Third Quarter 2021 Financial Results and Provides Update to Target Store Count for 2022 Launch of Halo Elevate NEW YORK, NY, November 10, 2021 -- Better Choice Company Inc. (NYSE BTTR) (the "Company" or "Better Choice"), a pet health and wel
Read more →SRXHDocument Better Choice Company Appoints Lionel Conacher and Arlene Dickinson to the Board of Directors
Better Choice Company Appoints Lionel Conacher and Arlene Dickinson to the Board of Directors NEW YORK, NY, October 1, 2021 - Better Choice Company (NYSE BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced that it has appointed two new me
Read more →SRXHDocument
BETTER CHOICE COMPANY BOARD OF DIRECTORS AUTHORIZE STOCK REPURCHASE PROGRAM NEW YORK, NY, August 17, 2021 -- Better Choice Company Inc. (NYSE BTTR) ("Better Choice" or "the Company"), an animal health and wellness company, today announced that its Board of Directors has authoriz
Read more →SRXHDocument Better Choice Company Reports Second Quarter 2021 Financial Results
Better Choice Company Reports Second Quarter 2021 Financial Results NEW YORK, NY, August 12, 2021 -- Better Choice Company Inc. (NYSE BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial results for the second quarter ende
Read more →SRXHDocument Better Choice Company Reports First Quarter 2021 Financial Results
Better Choice Company Reports First Quarter 2021 Financial Results NEW YORK, NY, May 13, 2021 -- Better Choice Company Inc. (OTCQX BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial results for the First Quarter ended Ma
Read more →SRXHDocument Better Choice Announces Appointment of Former Blue Buffalo Founding Shareholder, Gil Fronzaglia, to the Board of Directors
Better Choice Announces Appointment of Former Blue Buffalo Founding Shareholder, Gil Fronzaglia, to the Board of Directors NEW YORK - April 26, 2021 (GLOBE NEWSWIRE) - Better Choice Company (OTCQX BTTR) ("Better Choice"), an animal health and wellness company, today announces th
Read more →SRXHDocument Better Choice Announces 19% Growth in Q1 2021 Gross Sales Relative to Q4 2020 Gross Sales
Better Choice Announces 19% Growth in Q1 2021 Gross Sales Relative to Q4 2020 Gross Sales NEW YORK - April 20, 2021 (GLOBE NEWSWIRE) - Better Choice Company (OTCQX BTTR) ("Better Choice"), an animal health and wellness company, today announced preliminary Gross Sales of $13.4 m
Read more →SRXHDocument Better Choice Company Reports Fourth Quarter and Full Year 2020 Financial Results
Better Choice Company Reports Fourth Quarter and Full Year 2020 Financial Results NEW YORK, NY, March 31, 2021 -- Better Choice Company Inc. (OTCQX BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial results for the Fourt
Read more →SRXHDocument BETTER CHOICE COMPANY RETAINS EMERGING MARKETS CONSULTING, LLC (EMC)
BETTER CHOICE COMPANY RETAINS EMERGING MARKETS CONSULTING, LLC (EMC) AND WINNING MEDIA TO PROVIDE INVESTOR PUBLIC RELATIONS SERVICES NEW YORK - February 17, 2021 (GLOBE NEWSWIRE) - Better Choice Company (OTCQB BTTR) ("Better Choice"), an animal health and wellness company, is pl
Read more →SRXHDocument Better Choice Secures New Credit Facility Partnership New Long Term Credit Relationship Will Significantly Reduce Interest Expense and Extend Debt Maturities
Better Choice Secures New Credit Facility Partnership New Long Term Credit Relationship Will Significantly Reduce Interest Expense and Extend Debt Maturities NEW YORK - January 11, 2021 (GLOBE NEWSWIRE) - Better Choice Company (OTCQX BTTR) ("Better Choice"), an animal health an
Read more →SRXHDocument Better Choice Appoints Consumer Packaged Goods Industry Veteran, Scott Lerner, as New CEO -- With over 20 years of experience in the consumer packaged goods industry, Mr. Lerner has previously held positions at
Better Choice Appoints Consumer Packaged Goods Industry Veteran, Scott Lerner, as New CEO With over 20 years of experience in the consumer packaged goods industry, Mr. Lerner has previously held positions at PepsiCo, ConAgra Foods and Kimberly-Clark Monday, January 4, 2021 NEW
Read more →SRXHBetter Choice Company Reports Third Quarter and Year-to-Date 2020 Financial Results
Better Choice Company Reports Third Quarter and Year-to-Date 2020 Financial Results NEW YORK, NY, November 18, 2020 -- Better Choice Company, Inc. (OTCQB BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial results for the
Read more →SRXHBetter Choice Closes Third Tranche of Series F and Completes Equity Raise Totaling Cumulative $21.7M Final Tranche is Anchored by Iconic Consumer Packaged Goods Private Equity Firm, Cambridge Companies
Better Choice Closes Third Tranche of Series F and Completes Equity Raise Totaling Cumulative $21.7M Final Tranche is Anchored by Iconic Consumer Packaged Goods Private Equity Firm, Cambridge Companies SPG NEW YORK, October 27, 2020 (GLOBE NEWSWIRE) -- Better Choice Company Inc
Read more →SRXHBetter Choice Announces Closing of Expanded Series F Financing and Acceleration of Asian Expansion Management and Board Have Funded More than $11M to Support Growth
Better Choice Announces Closing of Expanded Series F Financing and Acceleration of Asian Expansion Management and Board Have Funded More than $11M to Support Growth NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB BTTR) ("Better Choice" or "the Company")
Read more →SRXHBetter Choice Closes $17.8M Insider-led Financing to Expand Its Rapidly Growing E-Commerce, Direct to Consumer and International Channels $45M Annual Revenue with Strong Top- and Bottom-line Projected Growth
Better Choice Closes $17.8M Insider-led Financing to Expand Its Rapidly Growing E-Commerce, Direct to Consumer and International Channels $45M Annual Revenue with Strong Top- and Bottom-line Projected Growth NEW YORK, October 2, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (O
Read more →SRXHBetter Choice Company Reports Second Quarter 2020 Financial Results
Better Choice Company Reports Second Quarter 2020 Financial Results NEW YORK, NY, August 18, 2020 -- Better Choice Company, Inc. (OTCQB: BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial results for the second quarter
Read more →SRXHInvestor Presentation
Investor Presentation August 4, 2020 Safe Harbor This presentation contains information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, referred to herein and which constitute "f
Read more →SRXHBetter Choice Company Announces New $7.5 Million Revolving Credit Facility with Citizens Bank at L+250 Interest Rate
Better Choice Company Announces New $7.5 Million Revolving Credit Facility with Citizens Bank at L+250 Interest Rate NEW YORK - July 20, 2020 -- Better Choice Company (OTCQB: BTTR) ("Better Choice"), an animal health and wellness company, today announced that it has entered into
Read more →SRXHBetter Choice Company Reports First Quarter 2020 Financial Results, including $12.3 million of Net Revenue
Better Choice Company Reports First Quarter 2020 Financial Results, including $12.3 million of Net Revenue NEW YORK, NY, June 25, 2020 -- Better Choice Company, Inc. (OTCQB: BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its finan
Read more →SRXHBetter Choice Company Reports Full Year 2019 Financial Results and Provides a Shareholder Update
Better Choice Company Reports Full Year 2019 Financial Results and Provides a Shareholder Update NEW YORK, NY, May 7, 2020 -- Better Choice Company, Inc. (OTCQB: BTTR) (the "Company" or "Better Choice"), an animal health and wellness company, today reported its financial result
Read more →SRXHBetter Choice Company Appoints Pet and Consumer Packaged Goods Industry Veteran, Werner von Pein, as Chief Executive Officer -- Company also appoints Michael Close to the Board of Directors -- New York, N.Y., (
Better Choice Company Appoints Pet and Consumer Packaged Goods Industry Veteran, Werner von Pein, as Chief Executive Officer Company also appoints Michael Close to the Board of Directors New York, N.Y., (February 11, 2020) - Better Choice Company, Inc. (OTCQB: BTTR) (the "Comp
Read more →SRXHBruce Linton Joins Better Choice Company as Special Advisor Management, the Board and key shareholders have voluntarily entered into a lock-up agreement for a twelve-month term representing 32% of the fully diluted outst
Bruce Linton Joins Better Choice Company as Special Advisor Management, the Board and key shareholders have voluntarily entered into a lock-up agreement for a twelve-month term representing 32% of the fully diluted outstanding shares of the Company NEW YORK, Sept. 17, 2019 (GLO
Read more →SRXHBetter Choice Company Appoints Walmart and PepsiCo Veteran Andreas Schulmeyer as Chief Financial Officer Schulmeyer Brings Nearly Two Decades of Strategic, Financial and E-Commerce Leadership Experience to Global Animal
Better Choice Company Appoints Walmart and PepsiCo Veteran Andreas Schulmeyer as Chief Financial Officer Schulmeyer Brings Nearly Two Decades of Strategic, Financial and E-Commerce Leadership Experience to Global Animal Health and Wellness CBD Company NEW YORK, N.Y. - July 9, 2
Read more →SRXHIncreasing Liquidity and Institutional Participation in the Cryptocurrency Markets April 2018(Symbol: SENZ) Safe Harbor Statement This presentation includes statements that are, or may be deemed, forward-looking statemen
Increasing Liquidity and Institutional Participation in the Cryptocurrency Markets April 2018(Symbol: SENZ) Safe Harbor Statement This presentation includes statements that are, or may be deemed, forward-looking statements.'' In some cases, these forward-looking statements can b
Read more →Competitive Position
How SRXH ranks across every disease it competes inCompetitive Position is a premium feature
See how SRXH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial